Abstract Embargo Information
Abstract Content Embargo (All Abstract Types)
Regular and Early Career Investigator Award Abstracts are embargoed until Nov. 3, 2026 at 9 a.m. ET. At that time, full Regular and Early Career Investigator Award Abstracts will be published as a preprint supplement in the Journal for ImmunoTherapy of Cancer (JITC). This includes content within the original abstract submitted.
Late-Breaking Abstracts – Clinical Only (LBAs) are embargoed until Nov. 6, 2026 at 9 a.m. ET. At that time, full LBAs will be published as a preprint supplement in the Journal for ImmunoTherapy of Cancer (JITC). This includes content within the original abstract submitted.
Poster Presentation Data Embargo
(Posters only): Any additional data that will be available on a poster that is beyond what was submitted in the abstract is embargoed until Nov. 6, 2026 at 9 a.m. ET. This embargo applies to poster-only presentations.
Oral Presentation Data Embargo
Any updated and/or new data that will be available in an oral presentation is embargoed until the date and time of the presentation. If the oral presenter is also creating a poster which includes updated and/or new data, the poster shares the same Oral Presentation Embargo date, not the poster embargo date specified above. This embargo applies to oral abstract presentations.